Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 9 of 9 for “"CDK5/p25"”.
-
Molecular modeling and SAR studies of CDK5/p25 selective inhibitors
… tangles. Cyclin dependent kinase 5 (CDK5) is a proline directed serine/threonine kinase, which expressed primarily in the central nervous system. In the biochemical process the CDK5-natural activator, p35 is cleaved by calpain to a shorter protein p25, which in turn …
-
Design and Synthesis of Novel Benzimidazoles and Aminothiazoles as Small Molecule Inhibitors of CDK5/p25
… synthesis and biological evaluation of novel CDK5/p25 small molecule inhibitors. Cyclin dependent kinase 5 (CDK5) is a proline directed serine/threonine kinase which plays an important role in the pathology of Alzheimer's disease (AD). CDK5/p25 has been implicated in hyperphosphorylation of …
-
INVESTIGATION OF NEUROPROTECTIVE TARGETS FOR PARKINSON’S DISEASE AND THEIR ROLE IN PATHOPHYSIOLOGY WITH A SECONDARY LOOK AT A MOLECULAR TARGET FOR SCHIZOPHRENIA
… factor (MANF) and cyclin-dependent 5 (CDK5)/p25 respectively) to support a multi-hit hypothesis in PD neural degeneration. Using behavioural and biochemical analysis, a reduction in MANF was found to participate in the ER stress hypothesis and CDK5/p25 hyperactivation is a viable …
-
TP5: A POTENTIAL THERAPEUTIC DRUG FOR PARKINSON’S DISEASE
… diseases, known as the hyperactivation of the Cdk5/p25 complex. This complex is an essential target to focus on the protection of neurons and prevent the pathology of PD to worsen as treatments are currently only temporary in symptom relief. Truncated Peptide 5 (TP5) is a Cdk5/p25 inhibitor …
-
Rethinking Alzheimer's Disease Therapeutic Systems Using Molecular Dynamics Simulations to Inform and Propel Drug Design.
… the hyperactivity of cyclin-dependent kinase 5 (CDK5), which, under normal conditions, plays a crucial role in neuronal functions such as learning, memory, and cell differentiation when activated by its physiological partners, p35 or p39. However, oxidative stress leads to the cleavage of p35 …
-
Design and Synthesis of Benzimidazoles as CDK5 Inhibitors and Progress toward the Total Synthesis of Tubulysin D
… of 1,4,6-trisubstituted benzimidazoles as CDK5 inhibitors and the progress toward the total synthesis of tubulysin D. Tubulysin is a natural product with potential anti-cancer activity. The two gamma-amino acids in the Tuv and Tup fragments of tubulysin were synthesized. Evans' …
-
Selective enzyme inhibition in the prevention of neuronal apoptosis : a molecular modelling study
… diseases. These enzymes include CDK5/p25 (Cyclin dependent kinase 5 in complex with activator protein p25), calpain I, caspase 3 and GSK313 (Glycogen synthase kinase 313). Inhibition of these enzymes will have the potential to counteract the neurodegeneration caused by various …
-
Mechanisms of palmitate induced amyloidogenesis in Alzheimer's Disease mediated by astrocytes
… protease, resulting in enhanced p25/Cdk5 activity, and in turn the phosphorylation and activation of STAT3, a transcription factor. STAT3 transcriptionally regulates the expression of both BACE1 and presenilin-1, a catalytic subunit of gamma-secretase, in primary neurons, …
-
Synthesis and biological evaluation of 7-azaindole-based chalcones and related compounds as protein kinase inhibitors
… disease-relevant protein kinases (CDK2/CyclinA, CDK5/ p25, CDK9/CyclinT, Haspin, PIM1, CK1ε, GSK-3β and ABL1 and LmCK1 (from the Leishmania major parasite)) and were considered active if they inhibited ≥ 70% of kinase activity. A majority of active compounds synthesised in this study are potent …